Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL VETERINARY THERAPEUTICS INDUSTRY
2.1 Summary about Veterinary Therapeutics Industry
2.2 Veterinary Therapeutics Market Trends
2.2.1 Veterinary Therapeutics Production & Consumption Trends
2.2.2 Veterinary Therapeutics Demand Structure Trends
2.3 Veterinary Therapeutics Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Anti-inflammatory
4.2.2 Parasiticides
4.2.3 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospitals
4.3.2 Veterinary Clinics
4.3.3 Drug Stores
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Anti-inflammatory
5.2.2 Parasiticides
5.2.3 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospitals
5.3.2 Veterinary Clinics
5.3.3 Drug Stores
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Anti-inflammatory
6.2.2 Parasiticides
6.2.3 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospitals
6.3.2 Veterinary Clinics
6.3.3 Drug Stores
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Anti-inflammatory
7.2.2 Parasiticides
7.2.3 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospitals
7.3.2 Veterinary Clinics
7.3.3 Drug Stores
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Anti-inflammatory
8.2.2 Parasiticides
8.2.3 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospitals
8.3.2 Veterinary Clinics
8.3.3 Drug Stores
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Anti-inflammatory
9.2.2 Parasiticides
9.2.3 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospitals
9.3.2 Veterinary Clinics
9.3.3 Drug Stores
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Bayer AG
10.1.2 Boehringer Ingelheim GmbH
10.1.3 Ceva Sante Animale
10.1.4 Dechra Pharmaceuticals PLC
10.1.5 Eli Lilly and Company (Elanco Animal Health)
10.1.6 Merck Animal Health
10.1.7 Sanofi (Merial Animal Health)
10.1.8 Virbac
10.1.9 Vetoquinol S.A.
10.1.10 Zoetis, Inc.
10.2 Veterinary Therapeutics Sales Date of Major Players (2017-2020e)
10.2.1 Bayer AG
10.2.2 Boehringer Ingelheim GmbH
10.2.3 Ceva Sante Animale
10.2.4 Dechra Pharmaceuticals PLC
10.2.5 Eli Lilly and Company (Elanco Animal Health)
10.2.6 Merck Animal Health
10.2.7 Sanofi (Merial Animal Health)
10.2.8 Virbac
10.2.9 Vetoquinol S.A.
10.2.10 Zoetis, Inc.
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
Table Veterinary Therapeutics Product Type Overview
Table Veterinary Therapeutics Product Type Market Share List
Table Veterinary Therapeutics Product Type of Major Players
Table Brief Introduction of Bayer AG
Table Brief Introduction of Boehringer Ingelheim GmbH
Table Brief Introduction of Ceva Sante Animale
Table Brief Introduction of Dechra Pharmaceuticals PLC
Table Brief Introduction of Eli Lilly and Company (Elanco Animal Health)
Table Brief Introduction of Merck Animal Health
Table Brief Introduction of Sanofi (Merial Animal Health)
Table Brief Introduction of Virbac
Table Brief Introduction of Vetoquinol S.A.
Table Brief Introduction of Zoetis, Inc.
Table Products & Services of Bayer AG
Table Products & Services of Boehringer Ingelheim GmbH
Table Products & Services of Ceva Sante Animale
Table Products & Services of Dechra Pharmaceuticals PLC
Table Products & Services of Eli Lilly and Company (Elanco Animal Health)
Table Products & Services of Merck Animal Health
Table Products & Services of Sanofi (Merial Animal Health)
Table Products & Services of Virbac
Table Products & Services of Vetoquinol S.A.
Table Products & Services of Zoetis, Inc.
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Veterinary Therapeutics Market Forecast (Million USD) by Region 2021f-2026f
Table Global Veterinary Therapeutics Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Veterinary Therapeutics Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Veterinary Therapeutics Market Forecast (Million USD) Share by Demand 2021f-2026f